» Articles » PMID: 32608178

Breast Cancer Survivors' Risk of Interval Cancers and False Positive Results in Organized Mammography Screening

Overview
Journal Cancer Med
Specialty Oncology
Date 2020 Jul 2
PMID 32608178
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Breast cancer survivors are increasing followed for new breast cancers / recurrences by mammography screening only. We aimed at assessing how often breast cancer survivors get a false positive or false negative result at mammography screening.

Methods: All mammography screenings performed between 2007 and 2017 in the Danish national mammography screening programme were included. Screenings in women with a breast cancer diagnosis prior to invitation were included in the "breast cancer survivors" group, while remaining screenings were included in the "no previous breast cancer" group. We compared the proportion of false positive screenings and the proportion of breast cancers detected at screening among breast cancer survivors and women without previous breast cancer. The analyses were further stratified according to whether the women had a diagnostic breast imaging in the 21 months prior to the screening.

Results: At initial screenings, breast cancer survivors had a significant lower false positive risk than other women, while the risk was similar at subsequent screenings. Breast cancer survivors had a significant lower proportion of breast cancers detected at screening compared to other women. This was true both for women who had a diagnostic breast imaging in the 21 months prior to screening and those who did not.

Conclusion: This study shows that breast cancers survivors have a smaller amount of their new breast cancers detected at mammography screening, when compare to the amount of new breast cancers detected at mammography screening among women without previous breast cancer. The lower sensitivity does not seem to be due to different behavior among breast cancer survivors.

Citing Articles

False negative breast cancers on imaging and associated risk factors: a single institution six-year analysis.

Franklin J, Hayes J, Knippa E, Dogan B Breast Cancer Res Treat. 2024; 205(3):507-520.

PMID: 38483757 DOI: 10.1007/s10549-024-07259-0.


Choice of Assessment and Subsequent Risk of Breast Cancer among Women with False-Positive Mammography Screening.

Sardini B, Jorgensen S, Larsen L, Elhakim M, Njor S Cancers (Basel). 2023; 15(6).

PMID: 36980754 PMC: 10046942. DOI: 10.3390/cancers15061867.


Routine and interval detection of locoregional breast cancer recurrences and risk of subsequent distant metastasis.

Eijkelboom A, de Munck L, de Vries M, Francken A, Hendriks M, Strobbe L Breast Cancer Res Treat. 2022; 197(1):123-135.

PMID: 36315307 PMC: 9823019. DOI: 10.1007/s10549-022-06757-3.


Breast cancer survivors' risk of interval cancers and false positive results in organized mammography screening.

Njor S, Vejborg I, Larsen M Cancer Med. 2020; 9(16):6042-6050.

PMID: 32608178 PMC: 7433834. DOI: 10.1002/cam4.3182.

References
1.
Fanizzi A, Basile T, Losurdo L, Bellotti R, Bottigli U, Dentamaro R . A machine learning approach on multiscale texture analysis for breast microcalcification diagnosis. BMC Bioinformatics. 2020; 21(Suppl 2):91. PMC: 7069158. DOI: 10.1186/s12859-020-3358-4. View

2.
Njor S, Vejborg I, Larsen M . Breast cancer survivors' risk of interval cancers and false positive results in organized mammography screening. Cancer Med. 2020; 9(16):6042-6050. PMC: 7433834. DOI: 10.1002/cam4.3182. View

3.
Lin N, Thomssen C, Cardoso F, Cameron D, Cufer T, Fallowfield L . International guidelines for management of metastatic breast cancer (MBC) from the European School of Oncology (ESO)-MBC Task Force: Surveillance, staging, and evaluation of patients with early-stage and metastatic breast cancer. Breast. 2013; 22(3):203-10. DOI: 10.1016/j.breast.2013.03.006. View

4.
Bolejko A, Hagell P, Wann-Hansson C, Zackrisson S . Prevalence, Long-term Development, and Predictors of Psychosocial Consequences of False-Positive Mammography among Women Attending Population-Based Screening. Cancer Epidemiol Biomarkers Prev. 2015; 24(9):1388-97. DOI: 10.1158/1055-9965.EPI-15-0060. View

5.
Gjerstorff M . The Danish Cancer Registry. Scand J Public Health. 2011; 39(7 Suppl):42-5. DOI: 10.1177/1403494810393562. View